Amal Therapeutics Company

Amal Therapeutics is a biotech start-up company based in Switzerland and Germany that specializes in developing therapeutic vaccines for cancer using its own cell penetrating peptide platform. The company was founded in 2012 as a spin-off from the University of Geneva.